| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
33,807 |
31,528 |
$2.65M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,792 |
22,038 |
$1.82M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,740 |
5,106 |
$977K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,731 |
11,798 |
$810K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,721 |
11,902 |
$769K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,349 |
7,374 |
$655K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,674 |
4,877 |
$636K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,553 |
5,160 |
$397K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,140 |
6,173 |
$344K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,840 |
1,697 |
$297K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,691 |
2,347 |
$253K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
867 |
839 |
$251K |
| 80053 |
Comprehensive metabolic panel |
29,350 |
24,495 |
$231K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,261 |
1,116 |
$175K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,073 |
975 |
$174K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,622 |
2,557 |
$161K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,057 |
2,702 |
$123K |
| 87420 |
|
2,160 |
2,110 |
$123K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,294 |
1,190 |
$121K |
| 71045 |
Radiologic examination, chest; single view |
15,624 |
13,890 |
$114K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,846 |
4,502 |
$92K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,587 |
2,247 |
$86K |
| 81025 |
|
8,414 |
7,662 |
$74K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
7,463 |
7,052 |
$71K |
| 81001 |
|
13,786 |
12,337 |
$61K |
| 59025 |
Fetal non-stress test |
771 |
567 |
$58K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,959 |
6,641 |
$52K |
| 71046 |
Radiologic examination, chest; 2 views |
2,282 |
2,146 |
$48K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,111 |
1,758 |
$47K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
705 |
622 |
$47K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,195 |
966 |
$43K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
499 |
453 |
$43K |
| G0378 |
Hospital observation service, per hour |
3,926 |
1,964 |
$39K |
| 81003 |
|
6,181 |
5,638 |
$37K |
| 82947 |
|
6,932 |
4,170 |
$36K |
| 73610 |
|
969 |
898 |
$36K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
794 |
745 |
$32K |
| 73630 |
|
1,154 |
1,041 |
$29K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,136 |
3,063 |
$29K |
| 87077 |
|
2,957 |
2,538 |
$28K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,601 |
1,156 |
$26K |
| 73130 |
|
831 |
747 |
$26K |
| 86900 |
|
1,051 |
959 |
$25K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
583 |
548 |
$24K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
446 |
363 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32,229 |
25,693 |
$22K |
| 01999 |
|
1,305 |
1,228 |
$20K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,610 |
9,760 |
$20K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,679 |
6,046 |
$19K |
| 87186 |
|
2,170 |
1,924 |
$17K |
| 84484 |
|
8,775 |
5,837 |
$17K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
483 |
159 |
$14K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
677 |
614 |
$14K |
| 73030 |
|
892 |
762 |
$13K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
441 |
414 |
$12K |
| 84702 |
|
2,046 |
1,583 |
$11K |
| 76377 |
|
1,064 |
875 |
$11K |
| 72100 |
|
917 |
857 |
$11K |
| 85610 |
|
6,052 |
4,831 |
$11K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,256 |
6,795 |
$10K |
| 73110 |
|
434 |
400 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
2,700 |
2,102 |
$10K |
| 76801 |
|
1,298 |
1,046 |
$10K |
| 80050 |
General health panel |
386 |
369 |
$8K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
913 |
764 |
$8K |
| 73564 |
|
338 |
300 |
$8K |
| 80061 |
Lipid panel |
2,427 |
2,157 |
$8K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,061 |
1,976 |
$7K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,015 |
1,732 |
$7K |
| 96376 |
|
1,853 |
1,085 |
$6K |
| 73502 |
|
256 |
230 |
$6K |
| 93971 |
|
392 |
348 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,176 |
1,962 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,503 |
1,422 |
$6K |
| 73562 |
|
204 |
180 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,341 |
5,142 |
$5K |
| 74018 |
|
118 |
108 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,143 |
2,231 |
$5K |
| 87070 |
|
1,288 |
1,193 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,533 |
1,446 |
$4K |
| 77066 |
Tomosynthesis, mammo |
39 |
39 |
$4K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
95 |
82 |
$4K |
| 87040 |
|
2,849 |
1,519 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
793 |
632 |
$3K |
| 85730 |
|
4,329 |
3,726 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
689 |
553 |
$3K |
| 83880 |
|
2,346 |
2,058 |
$3K |
| 76642 |
|
135 |
123 |
$3K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
12 |
12 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
75 |
69 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
42 |
35 |
$2K |
| 83605 |
|
3,235 |
2,553 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
398 |
330 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
440 |
352 |
$2K |
| 83735 |
|
4,777 |
4,000 |
$2K |
| 87210 |
|
1,099 |
1,038 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
164 |
150 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,557 |
2,494 |
$2K |
| 93970 |
|
57 |
51 |
$2K |
| 83690 |
|
8,052 |
7,015 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,405 |
1,293 |
$2K |
| 72040 |
|
104 |
102 |
$2K |
| 74022 |
|
68 |
63 |
$2K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
984 |
875 |
$2K |
| 73080 |
|
47 |
42 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,666 |
1,478 |
$2K |
| 84703 |
|
1,404 |
1,296 |
$2K |
| 76830 |
Ultrasound, transvaginal |
233 |
219 |
$2K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
17 |
13 |
$1K |
| 97162 |
|
31 |
25 |
$1K |
| 86850 |
|
632 |
576 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
433 |
402 |
$1K |
| 86140 |
|
580 |
496 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,130 |
2,751 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
4,849 |
4,247 |
$1K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
13 |
$1K |
| 94761 |
|
319 |
207 |
$1K |
| 71250 |
|
38 |
27 |
$985.48 |
| 71101 |
|
29 |
24 |
$975.45 |
| 85027 |
|
1,263 |
997 |
$845.75 |
| 73590 |
|
25 |
24 |
$840.78 |
| 0001A |
|
45 |
44 |
$827.36 |
| 73140 |
|
12 |
12 |
$720.24 |
| 87507 |
|
26 |
26 |
$686.36 |
| 76857 |
|
56 |
40 |
$680.88 |
| 0002A |
|
44 |
41 |
$658.64 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
566 |
284 |
$633.32 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,278 |
1,899 |
$626.24 |
| 85379 |
|
1,321 |
1,228 |
$619.99 |
| 82565 |
|
1,343 |
1,151 |
$515.71 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
58 |
51 |
$512.66 |
| 82435 |
|
762 |
682 |
$484.72 |
| 12001 |
|
28 |
27 |
$474.99 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
17 |
15 |
$466.59 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
715 |
612 |
$441.05 |
| 82550 |
|
524 |
431 |
$414.88 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
791 |
653 |
$411.70 |
| 84439 |
|
1,125 |
1,033 |
$364.33 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
947 |
819 |
$339.93 |
| 82553 |
|
41 |
38 |
$265.80 |
| 86901 |
|
1,037 |
946 |
$253.06 |
| 90715 |
|
390 |
354 |
$250.55 |
| J7050 |
Infusion, normal saline solution, 250 cc |
703 |
511 |
$171.12 |
| 82248 |
|
32 |
27 |
$142.68 |
| J1756 |
Injection, iron sucrose, 1 mg |
40 |
27 |
$135.66 |
| 85014 |
|
1,273 |
1,077 |
$126.18 |
| 82077 |
|
755 |
636 |
$122.93 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12 |
12 |
$109.48 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
29 |
26 |
$83.06 |
| 82570 |
|
219 |
171 |
$67.60 |
| 82607 |
|
161 |
143 |
$53.24 |
| 80076 |
|
34 |
27 |
$49.48 |
| 84520 |
|
1,009 |
891 |
$46.70 |
| 85652 |
|
224 |
207 |
$45.24 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
84 |
71 |
$42.85 |
| J2060 |
Injection, lorazepam, 2 mg |
376 |
307 |
$37.76 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
264 |
251 |
$37.38 |
| 84132 |
|
867 |
759 |
$28.42 |
| 84295 |
|
771 |
690 |
$18.45 |
| 82746 |
|
15 |
12 |
$14.83 |
| 82043 |
|
41 |
32 |
$10.50 |
| 84466 |
|
13 |
12 |
$3.38 |
| 84100 |
|
120 |
88 |
$1.56 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
215 |
196 |
$0.00 |
| 10061 |
|
12 |
12 |
$0.00 |
| 87076 |
|
13 |
13 |
$0.00 |
| 85007 |
|
31 |
30 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
176 |
166 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
18 |
13 |
$0.00 |
| 80143 |
|
223 |
186 |
$0.00 |
| 80179 |
|
371 |
313 |
$0.00 |
| 83540 |
|
29 |
26 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
14 |
12 |
$0.00 |
| 82010 |
|
16 |
13 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
191 |
167 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
16 |
15 |
$0.00 |
| 82728 |
|
41 |
37 |
$0.00 |
| 80051 |
|
102 |
85 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
52 |
39 |
$0.00 |
| 87205 |
|
37 |
29 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
35 |
25 |
$0.00 |
| 80047 |
|
152 |
133 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
52 |
25 |
$0.00 |
| 86308 |
|
13 |
13 |
$0.00 |
| 82330 |
|
18 |
18 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
23 |
18 |
$0.00 |